Affiliation:
1. Research Department Schoen Clinic Bad Aibling Bad Aibling Germany
2. Chair of Human Movement Science, Faculty of Sport and Health Science Technical University Munich Munich Germany
3. The Biorobotics Institute, Scuola Superiore Sant'Anna Pisa Italy
4. Department of Excellence in Robotics & AI Scuola Superiore Sant'Anna Pisa Italy
5. German Center for Vertigo and Balance Disorders (DSGZ), Ludwig‐Maximilians University of Munich (LMU) Munich Germany
Abstract
AbstractBackgroundParesis of the upper limb (UL) is the most frequent impairment after a stroke. Hybrid neuroprostheses, i.e., the combination of robots and electrical stimulation, have emerged as an option to treat these impairments.MethodsTo give an overview of existing devices, their features, and how they are linked to clinical metrics, four different databases were systematically searched for studies on hybrid neuroprostheses for UL rehabilitation after stroke. The evidence on the efficacy of hybrid therapies was synthesized.ResultsSeventy‐three studies were identified, introducing 32 hybrid systems. Among the most recent devices (n = 20), most actively reinforce movement (3 passively) and are typical exoskeletons (3 end‐effectors). If classified according to the International Classification of Functioning, Disability and Health, systems for proximal support are expected to affect body structures and functions, while the activity and participation level are targeted when applying Functional Electrical Stimulation distally plus the robotic component proximally. The meta‐analysis reveals a significant positive effect on UL functions (p < 0.001), evident in a 7.8‐point Mdiff between groups in the Fugl–Meyer assessment. This positive effect remains at the 3‐month follow‐up (Mdiff = 8.4, p < 0.001).ConclusionsHybrid neuroprostheses have a positive effect on UL recovery after stroke, with effects persisting at least three months after the intervention. Non‐significant studies were those with the shortest intervention periods and the oldest patients. Improvements in UL functions are not only present in the subacute phase after stroke but also in long‐term chronic stages. In addition to further technical development, more RCTs are needed to make assumptions about the determinants of successful therapy.
Subject
Biomedical Engineering,General Medicine,Biomaterials,Medicine (miscellaneous),Bioengineering
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献